LINC02360

Across TCGA pan-cancer cohorts, LINC02360 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC02360 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02360 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02360 expression acts as an unfavorable survival marker, although some lineages such as MESO and KIRP show a favorable association.

MESO, DLBC, and BRCA are the cancer types where LINC02360 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.503	0.277	<.001	84	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	72	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
KIRC	DFS	Median	II,III,IV	0.312	0.616	.002	32	view →
KICH	OS	Tertile	All	0.753	0.955	.007	30	view →
KIRP	DFS	Tertile	III,IV	1.000	0.323	.020	30	view →
CHOL	DFS	Tertile	All	1.000	0.225	.008	18	view →
OV	OS	Tertile	All	0.782	0.860	.018	18	view →
SARC	OS	Quartile	All	0.733	0.893	.001	18	view →
LIHC	DFS	Tertile	III,IV	0.151	0.430	.043	9	view →
READ	DFS	Tertile	II,III,IV	0.463	0.801	.044	9	view →
ESCA	DFS	Median	All	0.443	0.279	.026	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC02360–MESO (OS)

Open the MESO breakdown →